Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry

NCT03836521 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-02-11

No results posted yet for this study

Summary

The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.

Conditions

  • Bicuspid Aortic Valve

Interventions

DEVICE

Transcatheter aortic valve replacement

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
129 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-15
Primary Completion
2028-08-15
Completion
2028-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03836521 on ClinicalTrials.gov